SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
fatal
Lv1
48 积分
2023-05-21 加入
最近求助
最近应助
互助留言
Neutrophil–lymphocyte ratio predicts early outcomes in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: a multicenter analysis
8小时前
待确认
Early evaluation of severe immune checkpoint inhibitor-associated myocarditis: a real-world clinical practice
3天前
已完结
Sarcopenia and the rate of change of the neutrophil/lymphocyte ratio as predictors of pembrolizumab efficacy in advanced urothelial carcinoma
7天前
已完结
Human leucocyte antigen genotype association with the development of immune-related adverse events in patients with non-small cell lung cancer treated with single agent immunotherapy
1个月前
已完结
Predicting checkpoint inhibitors pneumonitis in non-small cell lung cancer using a dynamic online hypertension nomogram
1个月前
已完结
Predictive value of NLR and PLR for immune-related adverse events: a systematic review and meta-analysis
1个月前
已完结
Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma
1个月前
已完结
Neutrophil-to-lymphocyte ratio predicts therapy outcomes of transarterial chemoembolization combined with tyrosine kinase inhibitors plus programmed cell death ligand 1 antibody for unresectable hepatocellular carcinoma
1个月前
已完结
Neutrophil–lymphocyte ratio predicts early outcomes in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: a multicenter analysis
1个月前
已完结
Human leucocyte antigen genotype association with the development of immune-related adverse events in patients with non-small cell lung cancer treated with single agent immunotherapy
1个月前
已完结
没有进行任何应助
感谢
8个月前
感谢
8个月前
感谢
9个月前
感谢
1年前
感谢
1年前
感谢
1年前
感谢,速度真快
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论